![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Burg J L, Grover C M, Pouletty P, Boothroyd J C. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gonodii, by polymerase chain reaction. Journal of Clinical Microbiology 1989; 27: 1787–1792
- Cook A JC, Gilbert R E, Buffolano W, Zufferey J, Petersen E, Jenum P A. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. British Medical Journal 2000; 321: 142–147
- Dupouy-Camet J, Gavinet M F, Paugam A, Tourte Schaffer C. Transmission, incidence and prevalence of Toxoplasmosis. Med Mal Infect 1993; 23: 139–147
- El-Awady M K, El-Hossein L A, Ismail S M, Abdel-Aziz M T, El-Demellawy M A. Comparison between Toxoplasma gondii DNA and specific immunoglobulins during pregnancy. Eastern Mediterranean Health Journal 2000; 6: 888–897
- El-Hady H M. Toxoplasmosis among pregnant women in Abha, Saudi Arabia. Journal of Egyptian Society of Parasitology 1991; 21: 811–815
- Ertug S, Okyay P, Turkmen M, Yuksel H. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BioMed Central (BMC) Public Health 2005; 5: 66
- Ghazi H O, Telmesani A M, Mahomed M F. TORCH Agents in Pregnant Saudi Women. Medical Principles and Practice 2002; 11: 180–182
- Gratzl R, Sodeck G, Platzer P, Jager W, Graf J, Polak A. Treatment of toxoplasmosis in pregnancy: Concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid. European Journal of Clinical Microbiology and Infectious Diseases 2002; 21: 12–16
- Guy E C, Pelloux H, Lappalainen M, Aspock H, Habl A, Melby K K, Holberg-Pettersen M, Petersen E, Simon J, Ambroise-Thomas P. Inter laboratory comparrison of polymerase chain reaction for the detection of Toxoplasm gondii DNA added to sample of Amniotic fluid. European Journal of Clinical Microbiology and Infectious Disease 1996; 15: 836–839
- Hussein A H, Nagaty I M, Fouad M A. Evaluation of IgM-ELISA versus PCR in diagnosis of recent Toxoplasma gondii infection. Journal of Egyptian Society of Parasitology 2002; 32: 639–646
- Iqbal J, Khalid N. Detection of acute Toxoplasma gondii infection in early pregnancy by IgG avidity and PCR analysis. Journal of Medical Microbiology 2007; 56: 1495–1499
- Morris A, Croxson M. Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland. Journal of the New Zealand Medical Association 2004; 20: 117–U770
- Nimiri L, Pelloux H, Elkhatib L. Detection of Toxoplasma gondii DNA and specific antibodies in high-risk pregnant women. American Journal of Tropical Medicine and Hygiene 2004; 71: 831–835
- Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Database of Systematic Reviews 1999; 3: CD001684
- Pinard J A, Leslie N S, Irvine P J. Maternal serologic screening for Toxoplasmosis. Journal of Midwifery and Women's Health 2003; 48: 308–316, 386–387
- Remington J S, Thulliez P, Montoya J G. Recent developments for diagnosis of toxoplasmosis. Journal of Clinical Microbiology 2004; 42: 941–945
- Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. American Journal of Obstetric and Gynecology 2001; 97: 296–300
- Stray-Pedersen B. Treatment of toxoplasmosis in the pregnant mother and newborn child. Scandinavian Journal of Infectious Diseases Suppl 1992; 84: 23–31
- Vaneechoutte M, Van Eldere J. The possibilities and limitations of nucleic acid amplification technology in diagnostic microbiology. Journal of Medical Microbiology 1997; 46: 188–194